BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 8247035)

  • 41. Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft.
    Hwang S; Lee SG; Park KM; Kim KH; Ahn CS; Oh HB; Moon DB; Ha TY; Lim YS; Jung DH
    Liver Transpl; 2006 Jun; 12(6):993-7. PubMed ID: 16721765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.
    Loggi E; Bihl F; Chisholm JV; Biselli M; Bontadini A; Vitale G; Ercolani G; Grazi GL; Pinna AD; Bernardi M; Brander C; Andreone P
    J Hepatol; 2009 Mar; 50(3):625-30. PubMed ID: 19157623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pitfall of hepatitis B surface antigen testing in a kidney transplant recipient presenting hepatitis B reactivation.
    Romanet P; Vacher-Coponat H; Moal V; Botta-Fridlund D; Motte A; Colson P
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):671-4. PubMed ID: 21703961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection.
    Krawczyk M; Grat M; Kornasiewicz O; Lewandowski Z; Barski K; Ligocka J; Grat K; Antczak A; Skalski M; Patkowski W; Nyckowski P; Zieniewicz K; Grzelak I; Pawlak J; Alsharabi A; Wróblewski T; Paluszkiewicz R; Najnigier B; Dudek K; Remiszewski P; Smoter P; Grodzicki M; Korba M; Kotulski M; Cieślak B; Kalinowski P; Gierej P; Fraczek M; Rdzanek Ł; Stankiewicz R; Kobryń K; Nazarewski Ł; Giercuszkiewicz D; Piwowarska J; Brudkowska A; Andrzejewska R; Niewiński G; Kilińska B; Zarzycka A; Nowak R; Kosiński C; Korta T; Ołdakowska-Jedynak U; Sańko-Resmer J; Foroncewicz B; Ziółkowski J; Mucha K; Senatorski G; Paczek L; Habior A; Lechowicz R; Polański S; Pacho R; Andrzejewska M; Rowiński O; Kozieł S; Ziarkiewicz-Wróblewska B; Górnicka B; Hevelke P; Cianciara J; Wiercińska-Drapało A; Michałowicz B; Karwowski A; Szczerbań J
    Przegl Epidemiol; 2013; 67(1):5-10, 93-7. PubMed ID: 23745368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver transplantation in HBsAg-positive HBV-DNA--negative cirrhotics: immunoprophylaxis and long-term outcome.
    Grazi GL; Mazziotti A; Sama C; Jovine E; Stefanini F; Paladini R; Rossi R; Cavallari A
    Liver Transpl Surg; 1996 Nov; 2(6):418-25. PubMed ID: 9346687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.
    Müller R; Gubernatis G; Farle M; Niehoff G; Klein H; Wittekind C; Tusch G; Lautz HU; Böker K; Stangel W
    J Hepatol; 1991 Jul; 13(1):90-6. PubMed ID: 1918881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation.
    Xu X; Tu Z; Wang B; Ling Q; Zhang L; Zhou L; Jiang G; Wu J; Zheng S
    Liver Int; 2011 Nov; 31(10):1477-84. PubMed ID: 21745275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
    Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
    Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease.
    Steinmüller T; Seehofer D; Rayes N; Müller AR; Settmacher U; Jonas S; Neuhaus R; Berg T; Hopf U; Neuhaus P
    Hepatology; 2002 Jun; 35(6):1528-35. PubMed ID: 12029640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplantation in Asian patients with chronic hepatitis B.
    Ho BM; So SK; Esquivel CO; Keeffe EB
    Hepatology; 1997 Jan; 25(1):223-5. PubMed ID: 8985294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
    Yuan CH; Liu YF; Li GC
    Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; McCullough CS; Dickson RC; Caldwell SH; Pruett TL
    Transplantation; 1996 May; 61(9):1358-64. PubMed ID: 8629297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation.
    Gugenheim J; Baldini E; Ouzan D; Mouiel J
    Transplant Proc; 1997; 29(1-2):517-8. PubMed ID: 9123112
    [No Abstract]   [Full Text] [Related]  

  • 56. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.
    al-Hemsi B; McGory RW; Shepard B; Ishitani MB; Stevenson WC; McCullough C; Pruett TL
    Clin Transplant; 1996 Dec; 10(6 Pt 2):668-75. PubMed ID: 8996763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation.
    Lucey MR; Graham DM; Martin P; Di Bisceglie A; Rosenthal S; Waggoner JG; Merion RM; Campbell DA; Nostrant TT; Appelman HD
    Gut; 1992 Oct; 33(10):1390-6. PubMed ID: 1446866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis.
    Naumann U; Protzer-Knolle U; Berg T; Leder K; Lobeck H; Bechstein WO; Gerken G; Hopf U; Neuhaus P
    Hepatology; 1997 Aug; 26(2):478-84. PubMed ID: 9252162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
    Lens S; García-Eliz M; Fernández I; Castells L; Bonacci M; Mas A; Crespo G; Buti M; Prieto M; Forns X
    Liver Int; 2018 Nov; 38(11):1940-1950. PubMed ID: 29660249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus].
    Bismuth A; Arulnaden JL; Samuel D; David MF; Pichon F; Mathieu D; Farahmand H; Farrokhi P; Feray C; Brechot C
    Rev Fr Transfus Hemobiol; 1992 Mar; 35(2):107-23. PubMed ID: 1637419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.